Human platelets tau: a potential peripheral marker for Alzheimer's disease.

Platelets are a major peripheral reservoir of the amyloid-β protein precursor, so they have been considered as a potential biological marker of Alzheimer's disease (AD). Here, it is demonstrated that tau protein is also present in platelets and that the levels of oligomeric species of this protein could serve as a novel and reliable biological marker for AD. Blood samples were obtained from 15 AD patients and 10 paired-age controls and platelets were separated via differential centrifugation. The purity of platelets was determined by flow cytometry and microscopy and the presence of tau was determined by immunofluorescence and immunoblots with tau specific antibodies. Immunofuorescence and immunoblot patterns of platelets were positive for tau. Immunoblots also showed the presence of high molecular weight (HMW) variants of tau that appeared to correspond to oligomeric forms of the protein. The ratio of HMW tau respect to tau monomeric species was significantly higher in AD patients than controls. The present is the first description of the presence of tau in platelets. The analysis of different tau fractions in platelets could serve as a new biological marker for AD.

[1]  R. Maccioni,et al.  The revitalized tau hypothesis on Alzheimer's disease. , 2010, Archives of medical research.

[2]  Christopher Clark,et al.  Disease-modifying therapies for Alzheimer disease , 2007, Neurology.

[3]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[4]  K. Ashe,et al.  Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy , 2007, The Journal of Neuroscience.

[5]  R. Maccioni,et al.  Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects , 2006, Neurobiology of Aging.

[6]  F. Rothhammer,et al.  ApoE alleles and tau markers in patients with different levels of cognitive impairment. , 2005, Archives of medical research.

[7]  R. Maccioni,et al.  Biological markers of Alzheimer's disease and mild cognitive impairment. , 2004, Current Alzheimer research.

[8]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[9]  C. Caltagirone,et al.  Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. , 2003, Archives of neurology.

[10]  G. Lenzi,et al.  Amyloid precursor protein in platelets , 2001, Neurology.

[11]  L. Barbeito,et al.  The molecular bases of Alzheimer's disease and other neurodegenerative disorders. , 2001, Archives of medical research.

[12]  M. Luca,et al.  Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. , 2001, Archives of neurology.

[13]  W. Klunk.  Biological Markers of Alzheimer’s Disease , 1998, Neurobiology of Aging.

[14]  I. Fischer,et al.  Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration , 1997, Journal of Molecular Neuroscience.

[15]  J. Nunez,et al.  Diversity of High‐Molecular‐Weight τ Proteins in Different Regions of the Nervous System , 1994, Journal of neurochemistry.

[16]  J. Nunez,et al.  Heterogeneity of the High Molecular Weight τ Proteins in N115 Neuroblastoma Cells , 1993, Journal of neurochemistry.

[17]  F. Ricolfi,et al.  A τ‐Related Protein of 130 kDa Is Present in Alzheimer Brain , 1992 .

[18]  R. Liem,et al.  Primary structure of high molecular weight tau present in the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Kirschner,et al.  Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells , 1988, The Journal of cell biology.

[20]  G. Rao,et al.  Measurement of ionized calcium in normal human blood platelets. , 1988, Analytical biochemistry.

[21]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[22]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[23]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[24]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[25]  C. Caltagirone,et al.  Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. , 2002, Archives of neurology.